Genome-Wide CRISPR Screen - Drug Target Deconvolution
Scan the entire genome of your species of interest to determine where your drug molecules are targeting using our VERG platform.
Ranomics' streamlined Genome-Wide CRISPR screen enables the characterization of thousands of gene knockouts to help you identify your drug's main targets, as well as potential off-target interactions.
Our analyses can be conducted in multiple cell lines to assess whether where your drug binds in tissue-specific or disease phenotype-specific cell lines.
Accelerate cell-based studies with Ranomics and identify high-quality drug targets faster.